The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE:JNJ) (Janssen) announced today the publication of new data in the journal Nature showing that an early-stage clinical...
Johnson & Johnson (NYSE:JNJ) announced today that Paula A. Johnson, MD, MPH, President of Wellesley College, has been appointed to its Board of Directors.“I am excited to welcome Dr. Paula...
By Sam Boughedda Johnson & Johnson's (NYSE:JNJ) share price has plunged after a report by The Wall Street Journal stated that the company's talc unit wasn't in financial distress. As a...
By Geoffrey Smith Investing.com -- Stocks in focus in premarket trading. Please refresh for updates. 3M (NYSE:MMM) stock fell 4.5% after the company missed its forecasts for the fourth...
By Investing.com Staff Shares of Johnson & Johnson (NYSE:JNJ) rose in pre-open trading Tuesday after the pharmaceutical giant reported better-than-expected fourth quarter...
Johnson & Johnson (JNJ) reported Q4 EPS of $2.35, $0.11 better than the analyst estimate of $2.24. Revenue for the quarter came in at $23.7 billion versus the consensus estimate of $23.9...
Investing.com - J&J (NYSE: JNJ) reported fourth quarter EPS of $2.35, $0.11 better than the analyst estimate of $2.24. Revenue for the quarter came in at $23.7B versus the consensus...
By Oliver Gray Investing.com - U.S. stock futures were little changed during Monday’s evening trade after major indices finished the regular session higher as investors digested a fresh...
By Senad Karaahmetovic Amgen (NASDAQ:AMGN) has agreed to acquire Horizon Therapeutics (NASDAQ:HZNP), according to Bloomberg News. Amgen agreed to pay $116.5 for each HZNP share, valuing the...
By Sam Boughedda Credit Suisse analysts said Friday that the firm is initiating coverage of U.S. large-cap pharmaceuticals with four Outperform ratings, two Neutral ratings, and one...
By Sarina Isaacs, Reuters Investing.com - Here are the hottest pieces of M&A news from the past week, as covered first on InvestingPro+. Pan American Silver (NASDAQ:PAAS) Corp. and...
By Investing.com Staff Stocks edged lower on Monday but finished the month sharply higher, with the Dow rising 14% in October. Amid today's downside action, several rumors drove trading...
By Noreen Burke Investing.com -- Earnings season is ramping up with the four biggest U.S. companies by market value among those set to report results in the coming week. The U.S. is to...
(Bloomberg) -- Multiple large companies are highlighting the impact of the ever-stronger dollar on profits. That may undercut the optimism generated so far by a string of...
By Liz Moyer Investing.com -- U.S. stocks rose on Tuesday after strong earnings from Goldman Sachs and an activist stake in Salesforce set a positive tone for the trading session. At 9:38 ET...
By Ankika Biswas and Shreyashi Sanyal (Reuters) -U.S. stock index futures jumped on Tuesday as strong earnings from Goldman Sachs and Johnson & Johnson (NYSE:JNJ) lifted hopes that upbeat...
By Senad Karaahmetovic Shares of Johnson & Johnson (NYSE:JNJ) are up nearly 2% after the pharmaceutical giant reported better-than-expected {{erl-8177||Q3 results. JNJ reported an EPS...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Tuesday, October 18th. Please refresh for updates. Goldman Sachs (NYSE:GS) stock rose 2.8% after the investment...
Johnson & Johnson (JNJ) reported Q3 EPS of $2.55, $0.03 better than the analyst estimate of $2.52. Revenue for the quarter came in at $23.79 billion versus the consensus estimate of $23.46...
Investing.com - J&J reported on Tuesday third quarter {{erl-8177||earnings that beat analysts' forecasts and revenue that topped expectations. J&J announced earnings per share of...
By Oliver Gray Investing.com - U.S stock futures were trading higher during Monday’s evening deals, after major benchmark indices rallied during regular trade as solid earnings results from...
By Liz Moyer Investing.com -- Stocks surged on Monday, putting last week's downturn in the rearview mirror as strong earnings from Bank of America (NYSE:BAC) and other financial companies...
By Noreen Burke Investing.com -- U.S. earnings season gets underway against a background of worries that the Federal Reserve’s aggressive rate hike campaign could tip the economy into a...
By Scott Kanowsky Investing.com -- GlaxoSmithKline plc (LON:GSK) has announced that its vaccine for respiratory syncytial virus for adults aged 60 and above showed overall efficacy of...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
